Home Cart Sign in  
Chemical Structure| 152121-47-6 Chemical Structure| 152121-47-6

Structure of SB 203580
CAS No.: 152121-47-6

Chemical Structure| 152121-47-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

SB-203580 (Adezmapimod) is a p38 MAPK inhibitor with IC50 of 0.3-0.5 μM.

Synonyms: RWJ 64809; Adezmapimod; SB203850

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of SB 203580

CAS No. :152121-47-6
Formula : C21H16FN3OS
M.W : 377.43
SMILES Code : CS(=O)C1=CC=C(C=C1)C1=NC(=C(N1)C1=CC=NC=C1)C1=CC=C(F)C=C1
Synonyms :
RWJ 64809; Adezmapimod; SB203850
MDL No. :MFCD00922198
InChI Key :CDMGBJANTYXAIV-UHFFFAOYSA-N
Pubchem ID :176155

Safety of SB 203580

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H319
Precautionary Statements:P305+P351+P338

Related Pathways of SB 203580

MAPK
PI3K-AKT
TLR

Isoform Comparison

Biological Activity

Target
  • p38 MAPK

    p38 MAPK, IC50:0.3 μM-0.5 μM

In Vitro:

Cell Line
Concentration Treated Time Description References
iPSC-HPCs 15 μM 21 days Enhance T-cell differentiation and cell yield by strongly activating T-cell commitment genes PMC7814014
TNNT2 mutant iPSC-CMs 2.5 μM 72 h SB 203580, in combination with Gö 6976, significantly improved the contractility of TNNT2 mutant iPSC-CMs and rescued mitochondrial respiration defects and ATP levels through the activation of the ATF4-dependent serine biosynthesis pathway. PMC9794189
BV2 cells 10 µM 24 h SB203580 significantly reduced the levels of NLRP3 and IL-1β and enhanced TFEB-mediated autophagy. PMC8686293

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Hippocampal CA1 pyramidal neurons Intraperitoneal injection 20 mg/kg Single injection, lasting 20 minutes SB203580 blocked PTZ-induced Kv4.2-DPP6 complex dissociation, indicating the critical role of p38 in the dissociation of the Kv4.2-DPP6 complex. PMC7099064
mice Parkinson's disease model intraperitoneal injection 5 mg/kg every other day starting from 5 months of age until the end of 9 months SB203580 significantly improved motor activity, reduced dopaminergic neuronal loss, and restored synaptic vesicle loss. PMC8686293

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.65mL

0.53mL

0.26mL

13.25mL

2.65mL

1.32mL

26.49mL

5.30mL

2.65mL

 

Historical Records

Categories